Tonix Pharmaceuticals Holding Corp. (TNXP) Live Share Price, Invest From India

Tonix Pharmaceuticals Holding Corp. Stock Performance

as on April 7, 2026 at 5:11 am IST

Day's Low
Day's High
$13.70
Day's Price Range
$14.16
$13.77
0.51%
Downside
2.83%
Upside
52 Week's Low
52 Week's High
$11.60
52-Week Price Range
$69.97
$13.77
15.74%
Downside
408.13%
Upside

Tonix Pharmaceuticals Holding Corp. share price movements today

Previous Close: $13.90
Open: $13.94
Volume: 247.5K
Day's Low - High: $13.70 - $14.16
52 Week Low - High: $11.60 - $69.97

Tonix Pharmaceuticals Holding Corp. Historical Returns

1 Month Return: + 3.35 %
3 Month Return: -9.51 %
1 Year Return: -11.13 %
3 Year Return: -99.88 %
5 Year Return: -100 %

Tonix Pharmaceuticals Holding Corp. Stock Fundamentals & Key Indicators

Check Tonix Pharmaceuticals Holding Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$197.5M

EPS (TTM)

-8.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-123.8M

Revenue (TTM)

13.1M

Profit Margin

0.00%

Return On Equity TTM

-64.48%

Tonix Pharmaceuticals Holding Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tonix Pharmaceuticals Holding Corp. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tonix Pharmaceuticals Holding Corp.	BUY	$197.5M	-100%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.3B	124.53%	136.85	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$111.4B	103.77%	28.66	32.94%
Beone Medicines Ltd	NA	$35.7B	NA	126.85	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.5B	59.16%	18.38	31.41%

Stock Returns calculator for Tonix Pharmaceuticals Holding Corp. Stock including INR - Dollar returns

The Tonix Pharmaceuticals Holding Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tonix Pharmaceuticals Holding Corp. investment value today

Current value as on today

₹95,403

Returns

-₹4,597

(-4.6%)

Returns from Tonix Pharmaceuticals Holding Corp. Stock

-₹11,957 (-11.96%)

Dollar Impact

₹7,359 (+7.36%)

Analyst Recommendation on Tonix Pharmaceuticals Holding Corp. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Tonix Pharmaceuticals Holding Corp.. Average target price of $54.33

Tonix Pharmaceuticals Holding Corp. Share Price Target

Get share price movements and forecasts by analysts on Tonix Pharmaceuticals Holding Corp..

What analysts predicted

74.65%UPSIDE

Target Price

$54.33

Current Price

$13.77

Analyzed by

8 Analysts

Target

$54.33

Tonix Pharmaceuticals Holding Corp. target price $54.33, a slight upside of 74.65% compared to current price of $13.77. According to 8 analysts rating.

Tonix Pharmaceuticals Holding Corp. Stock’s Investor Sentiment and Interest

Search interest for Tonix Pharmaceuticals Holding Corp. Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 7, 2026 to April 6, 2026

Change:-30% versus previous 30 day period

Tonix Pharmaceuticals Holding Corp. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	3	3	2	2	2	2	2	1	3	5
Gross Profit	1	1	0	-1	1	1	1	-1	1	4
Operating Income	-28	-27	-21	-18	-15	-22	-16	-28	-33	-48
EBITDA	-27	-	-20	-17	-15	-21	-16	-27	-31	-48
Interest Expense	-	-	1	-	0	-	-	-	-	0
Depreciation	1	1	1	1	0	0	0	0	0	0
Income Before Tax	-27	-27	-14	-78	-14	-22	-16	-28	-32	-46
Income Tax Expense	-1	-	-1	-	-	0	-	-	-	-
Net Income	-27	-27	-14	-78	-14	-22	-16	-28	-32	-46
Net Profit Margin	-701.30%	-723.00%	-601.89%	-3567.75%	-503.65%	-856.24%	-692.84%	-1415.02%	-972.95%	-870.32%

Tonix Pharmaceuticals Holding Corp. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	2	-	9	7	10	13
Gross Profit	-38	-21	-26	-28	-50	-92	-112	3	2	6
Operating Income	-38	-21	-26	-28	-50	-92	-112	-118	-136	-125
EBITDA	-38	-21	-26	-28	-50	-92	-110	-114	-74	-123
Interest Expense	-	-	-	-	-	0	7	-	1	0
Depreciation	-	0	0	0	0	0	1	3	3	1
Income Before Tax	-38	-21	-26	-28	-50	-92	-110	-116	-130	-124
Income Tax Expense	0	0	0	0	0	0	4	0	-1	-
Net Income	-38	-21	-26	-28	-50	-92	-115	-116	-130	-124
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-1729.17%	0.00%	-1274.00%	-1501.78%	-1288.25%	-946.22%

Tonix Pharmaceuticals Holding Corp. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-27	-14	-78	-14	-22	-16	-28	-32	-46
Operating Cash Flow	-22	-17	-9	-18	-14	-16	-14	-28	-39
Investing Cash Flow	-	0	0	0	0	0	-2	0	-1
Financing Cash Flow	40	0	7	42	85	49	10	94	59
Change in Cash	17	-17	-2	24	70	32	-6	65	18

Tonix Pharmaceuticals Holding Corp. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-21	-26	-28	-50	-92	-110	-116	-130	-124
Operating Cash Flow	-19	-23	-26	-48	-75	-98	-102	-60	-99
Investing Cash Flow	7	0	0	-8	-35	-48	-29	0	-4
Financing Cash Flow	18	23	12	123	212	87	36	134	214
Change in Cash	6	0	-13	65	101	-58	-94	73	108

Global Institutional Holdings in Tonix Pharmaceuticals Holding Corp.

Funds	Holdings
Charles Schwab Investment Management Inc	0.24%
Susquehanna International Group, LLP	0.21%
Millennium Management LLC	0.41%
Abacus Wealth Partners, LLC	0.12%
The Goldman Sachs Group Inc	0.19%

See all

Insights on Tonix Pharmaceuticals Holding Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, TNXP stock has moved up by 15.5%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 1.99M → 5.39M (in $), with an average increase of 39.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.3% return, outperforming this stock by 46.4%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 51.1% return, outperforming this stock by 151.0%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -16.82M → -46.91M (in $), with an average decrease of 42.6% per quarter

About Tonix Pharmaceuticals Holding Corp.

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

Organisation	Tonix Pharmaceuticals Holding Corp.
Headquarters	200 Connell Drive, Berkeley Heights, NJ, United States, 07928
Industry	Health Technology
CEO	Dr. Seth Lederman M.D.
E-voting on shares	Click here to vote

Key Management of Tonix Pharmaceuticals Holding Corp.

Name	Title
Mr. Thomas Englese M.B.A.	Executive Vice President of Commercial Operations
Dr. Gregory M. Sullivan M.D.	Chief Medical Officer & Secretary
Ms. Irina Ishak	General Counsel
Dr. Darryl Rideout Ph.D.	Executive Vice President of Experimental Chemistry
Dr. Zeil Rosenberg M.D., M.P.H.	Executive Vice President of Medical
Mr. Ganesh Kamath	Head of Market Access
Dr. Seth Lederman M.D.	Co-Founder, President, CEO & Chairman
Mrs. Jessica Edgar Morris	Chief Operating Officer
Dr. Sina Bavari Ph.D.	Executive Vice President of Infectious Disease Research & Development

FAQs

What is Tonix Pharmaceuticals Holding Corp. share price today?

Tonix Pharmaceuticals Holding Corp. share price today is $13.77 as on April 6, 2026 at 11:41 pm IST. Tonix Pharmaceuticals Holding Corp. share today touched a day high of $14.16 and a low of $13.7.

What is the 52 week high and 52 week low for Tonix Pharmaceuticals Holding Corp. share?

Tonix Pharmaceuticals Holding Corp. share touched a 52 week high of $69.97 on August 14, 2025 and a 52 week low of $11.6 on March 30, 2026. Tonix Pharmaceuticals Holding Corp. stock price today i.e. April 6, 2026 at 11:41 pm IST is trending at $13.77,which is 80.32% down from its 52 week high and 18.68% up from its 52 week low.

What is Tonix Pharmaceuticals Holding Corp.'s market capitalisation today?

Tonix Pharmaceuticals Holding Corp. market capitalisation is $0.00T as on April 6, 2026 at 11:41 pm IST.

How to invest in Tonix Pharmaceuticals Holding Corp. Stock (TNXP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tonix Pharmaceuticals Holding Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tonix Pharmaceuticals Holding Corp. Shares that will get you 0.1089 shares as per Tonix Pharmaceuticals Holding Corp. share price of $13.77 per share as on April 6, 2026 at 11:41 pm IST.

What is the minimum amount required to buy Tonix Pharmaceuticals Holding Corp. Stock (TNXP) from India?

Indian investors can start investing in Tonix Pharmaceuticals Holding Corp. (TNXP) shares with as little as ₹93.06 or $1 (as of April 6, 2026 at 11:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹930.60 in Tonix Pharmaceuticals Holding Corp. stock (as per the Rupee-Dollar exchange rate as on April 6, 2026 at 11:41 pm IST). Based on Tonix Pharmaceuticals Holding Corp. share’s latest price of $13.77 as on April 6, 2026 at 11:41 pm IST, you will get 0.7262 shares of Tonix Pharmaceuticals Holding Corp.. Learn more about fractional shares .

What are the returns that Tonix Pharmaceuticals Holding Corp. has given to Indian investors in the last 5 years?

Tonix Pharmaceuticals Holding Corp. stock has given -100% share price returns and 26.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?